Top Markets
Coin of the day
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD

Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD

300534
Rank in Stocks #11766
Gansu Longshenrongfa Pharmaceutical Industry Co.,Ltd operates as a... Gansu Longshenrongfa Pharmaceutical Industry Co.,Ltd operates as a pharmaceutical enterprise, focusing on the research, development, manufacturing, and commercialization of traditional Chinese medicines, health supplements, and active pharmaceutical ingredients (APIs). Its extensive product line includes therapeutic remedies such as Yuanhu Analgesic dropping pills, Qiwei Wenyang capsules, Maxing cough capsules, Shuxinning tablets, Panax notoginseng pills, Anti-inflammatory and gallbladder tablets, Children's Qingfei cough tablets, Pediatric Qinggan tablets, Suanzaoren oil dropping pills, Xiaoshuan Tongluo tablets, Xiaoyanlidan tablets, Compound Danshen tablets, Astragalus Angelica capsules, and berberine tannin films. Beyond its core manufacturing, the company is actively involved in the cultivation, procurement, processing, and distribution of Chinese medicinal raw materials. Its operations further encompass project investment and management, alongside the import, sale, logistics, and export of pharmaceutical goods. Established in 2002, Gansu Longshenrongfa Pharmaceutical Industry Co.,Ltd is headquartered in Lanzhou, China.
Share Price
$2.18
Last synced: 2026-08-28
Market Cap
$661.58M
Change (1 day)
-13.01%
Change (1 year)
52.92%
Country
CN
Trade Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD (300534)

Category

P/E ratio for Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD (300534)
P/E ratio as of 2026 TTM: 0
According to Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.